LexisNexis® Mealey's™ Hormone Replacement Therapy Legal NewsThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

499 records returned

Yaz / Yasmin Plaintiffs Seek Creation Of MDL In Northern District Of OhioEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
WASHINGTON, D.C. - Counsel representing plaintiffs who claim that they suffered injuries as a result of using Yaz or Yasmin oral contraceptive pills on July 24 filed a petition before the Judicial Panel on Multidistrict Litigation to centralize their lawsuits before U.S. Judge James G. Carr of the Northern District of Ohio (In re: Yaz/Yasmin Products liability Litigation, MDL No. 2100, JPMDL). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Federal Judge Stays Proceedings In 5 California Yaz / Yasmin SuitsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
OAKLAND, Calif. - A federal judge in California on Aug. 5 stayed proceedings in five cases involving injuries allegedly caused by the use of Bayer Corp.'s Yaz and/or Yasmin birth control pills pending a decision from the Judicial Panel on Multidistrict Litigation on whether to centralize the cases (Bridget Tanner, et al. v. Bayer Corp., et al., No. C 09-1558; Stephanie Ivey v. Bayer Corp. et al., No. C 09-1904; Dawn Voss v. Bayer Corp., et al., No. C 09-0905; Tamara Jirbi v. Bayer Corp., et al., No. C 09-2416; Bieanica White v. Bayer Corp., et al., No. C 09-2417, N.D. Calif.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Yaz Complaint Says Decedent Died Of Lung Blood ClotsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
COUNCIL BLUFFS, Iowa - A complaint was filed July 22 in an Iowa federal court alleging that a woman who used Yaz birth control for nine months developed pulmonary emboli and died (Jill Fender, et al. v. Bayer Corporation, et al., No. 09-24, S.D. Iowa, W. Div.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Complaint Alleges Yaz Caused Deep Vein ThrombosisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BENTON, Ill. - An Illinois woman on July 24 filed a complaint in Illinois federal court, alleging that her use of Yaz birth control pills caused her to develop deep vein thrombosis (Brenda Hill v. Bayer Corporation, et al., No. 09-567, S.D. Ill., Benton Div.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Texas Woman Says Yasmin Use Resulted In Deep Vein Thrombosis, Pulmonary EmbolismEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SHERMAN, Texas - A Texas woman filed a lawsuit in federal court on July 22 against the makers of Yasmin, alleging that her use of the oral contraceptive caused her to suffer a deep vein thrombosis and pulmonary embolism in July 2008 (Alaina Klarquist v. Bayer Corp., et al., No. 09-09-cv-00345-RAS-DDB, E.D. Texas). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Divided Federal Circuit Finds Bayer's Patent For Yasmin InvalidEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
WASHINGTON, D.C. - The Federal Circuit U.S. Court of Appeals on Aug. 5 found Bayer Schering Pharma AG's patent for Yasmin invalid after finding that the advances in the use of drospirenone, the progestin component of the birth control pill, that led to its creation were too obvious for a company to patent (Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals, Inc. v. Barr Laboratories, Inc., No. 2008-1282, Fed. Cir.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Minnesota Appeals Court Affirms Inadequate Causation Rulings In HRT LawsuitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. PAUL, Minn. - The Minnesota Court of Appeals on July 21 upheld a trial court judge's decision to award summary judgment to Wyeth after finding that a woman failed to provide sufficient scientific evidence to support her contention that ingesting hormone replacement therapy for nearly 20 years caused her to develop breast cancer, because the judge did not err in concluding that the woman's experts were not qualified and because the experts' specific causation theories were not reliable (Patricia Zandi v. Wyeth, et al., No. A08-1455, Minn. App.; 2009 Minn. App. Unpub. LEXIS 785; See November 2007, Page 4). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Prempro MDL Judge Unseals Documents Concerning Wyeth's Ghostwriting PracticesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - The federal judge presiding over the Prempro multidistrict litigation on July 24 granted requests from the publisher of the Public Library of Science (PLOS) medical journal, the New York Times Co. and the Plaintiffs' Steering Committee (PSC) to unseal documents pertaining to Wyeth's ghostwriting practices (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-CV-1507, E.D. Ark.; See July 2009, Page 4). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Wyeth Calls Motions To De-Designate Ghostwriting Documents A 'Sideshow'Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - Wyeth says in a July 18 opposition brief filed in the federal Prempro multidistrict litigation that it should not be required to defend the confidential status of documents relating to the ghostwriting of medical articles on the safety of hormone replacement therapy because it has not engaged in the practice for five years and that the current requests for release of the information is a "sideshow" intended to pressure the drug company into settling the litigation (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-CV-1507, E.D. Ark.; See July 2009, Page 4). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Judge Says Ruling Finding Prempro Claims Untimely Should Be AffirmedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - A Pennsylvania state court judge held July 8 that his previous ruling awarding summary judgment to Wyeth in a Prempro products liability case should be upheld because Pennsylvania law does not require a plaintiff to know of a definitive association between an injury and its possible cause to trigger the statute of limitations (Mildred Edwards, et al. v. Wyeth Pharmaceuticals Inc., et al., No. 060403669, Pa. Comm. Pls., Philadelphia Co.; 2009 Phila. Ct. Com. Pl. LEXIS 133). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

New Judge Appointed To Preside Over New Jersey HRT Mass TortEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TRENTON, N.J. - Middlesex County Superior Court Judge Jessica R. Mayer will replace Judge Jamie Happas in presiding over New Jersey's mass tort proceedings for cases involving injuries allegedly caused by hormone replacement therapy beginning Sept. 1, according to a notice to the bar entered Aug. 7 (In re: HRT Litigation, Case No. 266, N.J. Super., Middlesex Co.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

NuvaRing MDL Judge Denies Makers' Request To Dismiss Master ComplaintEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. LOUIS - The federal judge presiding over the NuvaRing products liability multidistrict litigation on Aug. 6 denied the manufacturers' motion to dismiss the plaintiffs' master complaint after finding the filing of the document was intended to act as an administrative tool listing all of the claims in the litigation (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

NuvaRing MDL Judge Rejects Manufacturers' Request To Share E-discovery CostsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. LOUIS - The federal judge presiding over the NuvaRing multidistrict litigation on Aug. 11 denied the manufacturers' request for plaintiffs to share the costs of producing electronically stored information after finding that the companies failed to establish that they have been subject to any more burdensome or expensive discovery than is normally incurred in complex litigation cases (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

NuvaRing MDL Judge Schedules Science Day Presentations For Dec. 1Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. LOUIS - On Dec. 1, attorneys and experts in the NuvaRing multidistrict litigation will hold educational presentations explaining the types of injuries allegedly caused by use of the hormonal contraceptive device, the effect the combination of hormones in the product has when administered and the terminology used to discuss the product and its injuries, a federal judge in Missouri ruled July 22 (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08-md-1964, E.D. Mo.; See March 2009, Page 13). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

New Judge Named To Preside Over New Jersey Ortho Evra Mass TortEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TRENTON, N.J. - A new judge will preside over New Jersey's Ortho Evra mass tort proceedings beginning Sept. 1, according to a notice to the bar signed Aug. 7 by the chief justice of the New Jersey Supreme Court (In re: Ortho Evra Birth Control Patch Litigation, Case No. 275, N.J. Super., Middlesex Co.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - August 18, 2009 Category: Medical Law Source Type: info

Prempro MDL PSC Seeks To Remove Confidentiality Of Ghostwriting DocumentsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - The Plaintiffs' Steering Committee (PSC) in the Prempro multidistrict litigation on July 1 moved to de-designate the confidential status of documents describing Wyeth's involvement in the ghostwriting of articles that downplayed the risks associated with the use of hormone replacement therapy, arguing that the public has a right to know about the practice and that the information does not contain trade secrets or proprietary information (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-CV-1507, E.D. Ark.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Medical Journal Seeks Access To Wyeth's Ghostwriting PracticesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - A nonprofit medical journal on June 11 asked the federal judge presiding over the Prempro multidistrict litigation to give it access to sealed information regarding ghostwriting practices Wyeth allegedly used in its promotion of hormone replacement therapy because the drug maker has never shown good cause as to why the information should be kept confidential and because there is a great public interest in the ghostwriting practices of pharmaceutical companies (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-cv-1507, E.D. Ark.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

New York Times Says Public Should Know About Wyeth's Ghostwriting PracticesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - Just days after the Public Library of Science moved to intervene in the Prempro multidistrict litigation seeking to vacate an order keeping information about Wyeth's ghostwriting practices confidential, the New York Times Co. on June 17 filed a similar motion, arguing that the public has a right to know about a practice that has become standard in the pharmaceutical industry (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-cv-1507, E.D. Ark.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Pennsylvania Judge Says Rulings Finding Claims Time-Barred Are CorrectEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - Four separate rulings awarding summary judgment to Wyeth in lawsuits brought by plaintiffs who claim that their use of the company's hormone replacement therapies caused them to develop breast cancer should be upheld, a Pennsylvania Common Pleas Court judge said in opinions handed down June 15, because there was sufficient information available to the plaintiffs at the time of their cancer diagnosis to support the theory that their injuries could have been caused by their use of the drugs (Linda Crowe v. Wyeth Inc., et al., No. 1128, Pa. Comm. Pls., Philadelphia Co.; 2009 Phila. Ct. Com. Pl. LEXIS 100). Fu...
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Generic HRT Makers Say Woman Did Not Identify Their Products In LawsuitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - Three manufacturers of generic hormone replacement therapies on June 29 moved to dismiss a woman's claims in the federal Prempro multidistrict litigation court in the Eastern District of Arkansas that her use of their drugs caused her to develop breast cancer because she did not identify in her complaint which of the companies' products she used (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03-CV-1507, Sharon McCall v. Wyeth, et al., No. 09-CV-00023, E.D. Ark.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Distributor Says Woman's Fraud Claims Lack Specificity, Should Be DismissedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
OAKLAND, Calif. - A California-based drug distributor on July 7 moved to dismiss a woman's claims sounding in fraud and negligent misrepresentation from her lawsuit against the manufacturers of the oral contraceptives Yaz and Yasmin because her allegations lack the specificity required under Federal Rule of Civil Procedure 9(b) (Bieanca White v. Bayer Corp., et al., No. C 09-02417-SBA, N.D. Calif.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Judge Refuses To Remand Louisiana Couple's Yasmin SuitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
OAKLAND, Calif. - A federal judge on June 16 rejected a Louisiana couple's request to remand their Yasmin products liability lawsuit to California state court because McKesson Corp., the California distributor named as a defendant in the case, was not served with a copy of the complaint until after the action was removed to federal court by the makers of the oral contraceptive (Bridget Renee Tanner, et al. v. Bayer Corp., et al., No. C 09-1558 SBA, N.D. Calif.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Ohio Law Firm Files 4 Lawsuits Alleging Injuries Caused By Oral ContraceptivesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - The Cincinnati law firm of Burg Simpson Eldredge Hersh & Jardine filed four lawsuits in federal courts in Ohio and Wisconsin between July 7 and July 10 on behalf of individuals who claim that they sustained thrombotic injuries as a result of using Yaz or Yasmin and who contend that the manufacturers of the oral contraceptives failed to properly warn users of the drugs about the risks associated with the progestin drospirenone (Marlene Meadows v. Bayer Corp., et al., No. 09-CV-1574, N.D. Ohio). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Couple Says Contraceptive Use Necessitated Removal Of Woman's GallbladderEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - A Nebraska couple says in a June 17 lawsuit filed against the makers of Yaz and Yasmin in Pennsylvania federal court that the woman's use of the oral contraceptives caused her to sustain injuries that required the removal of her gallbladder in July 2008 and that the defendant companies failed to warn consumers about the association between the use of the drugs and such injuries (Silvia F. Galvan, et al. v. Bayer Corp., et al., No. 09-CV-2937, E.D. Pa.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

New Study Links Hormone Therapy Use To Increased Risk Of Ovarian CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CHICAGO - A study published July 15 revealed that postmenopausal women using hormone replacement therapy, regardless of its formulation, duration of use, administration or dose of estrogen are at an increased risk of developing ovarian cancer compared with women who have never use the drugs. Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - July 21, 2009 Category: Medical Law Source Type: info

Plaintiff's Statement Unable To Support Causation In Ortho Evra Injury CaseEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - The manufacturers of Ortho Evra were awarded summary judgment by a federal judge in Ohio June 3 after he found that a plaintiff's statement regarding a thromboembotic event his daughter allegedly suffered while using the birth control patch was insufficient to demonstrate a causal link between her use of the product and the injury (In re: Ortho Evra Products Liability Litigation, MDL No. 1742, Case No. 06 cv 40000, Luis R. Santana-Guillen v. Johnson & Johnson, et al., No. 07 oe 40157, N.D. Ohio; 2009 U.S. Dist. LEXIS 46845). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Doctor's Affidavit Enough To Support Ortho Evra Injury ClaimEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - A doctor's affidavit confirming that a woman was using Ortho Evra when she suffered a pulmonary embolism was enough to support a couple's product liability claims against the manufacturers of the birth control patch, a federal judge in Ohio ruled May 11 in denying the defendants' request for summary judgment (In re: Ortho Evra Products Liability Litigation, MDL 1742, Case No. 06 cv 40000, Meloney Wright, et al. v. Ortho McNeil Corp., et al., No. 07 oe 40423, N.D. Ohio; 2009 U.S. Dist. LEXIS 41228). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Federal Judge Dismisses Minor Son's Claims In Ortho Evra LawsuitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - Claims asserted on behalf of a minor child in an Ortho Evra injury case were dismissed June 3 by a federal judge in Ohio because the child was not a "person" under Puerto Rico law since he was not born or conceived at the time his mother suffered a stroke as a result of using the birth control patch (In re: Ortho Evra Products Liability Litigation, MDL 1742, Case No. 06 cv 40000, Joanna Figueroa Garcia, et al. v. Johnson & Johnson, et al., No. 07 oe 40135, N.D. Ohio; 2009 U.S. Dist. LEXIS 46837). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Provera Maker Says Summary Judgment Award Should Not Be DisturbedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
NEW BRUNSWICK, N.J. - A ruling awarding summary judgment to the manufacturers of Premarin, Prempro and Provera should stand, the maker of Provera says in a May 13 brief filed in New Jersey appellate court, because the trial judge properly found that two exceptions to New Jersey's Products Liability Act (NJPLA) where a warning label approved by the Food and Drug Administration could be found to be inadequate were inapplicable (Dora Bailey, et al. v. Wyeth Inc., et al., No. A-006251-07T1, Loretta Deboard v. Wyeth Inc., et al., No. A-006230-07T1, N.J. Super., App. Div., See August 2008, Page 7). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

NuvaRing Maker Says Failure To Produce Fact Sheets Warrants DismissalEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. LOUIS - Two plaintiffs' failure to timely produce their plaintiff's fact sheets (PFS) with medical and pharmacy records constitutes bad faith and should result in the dismissal of their complaints, the makers of the NuvaRing contraceptive say in a June 1 motion to dismiss (In re: NuvaRing Products Liability Litigation, MDL 1964, Case No. 08 MD 1964, E.D. Mo.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Obama Orders Halt, Review Of Regulatory Preemption PreamblesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
WASHINGTON, D.C. - President Obama on May 20 moved to undo Bush administration preemption regulations by ordering department and agency heads not to include preemption preambles and to review past preemption preambles. Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

New Research Suggests Prempro Makes Lung Cancer More DeadlyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO, Fla. - Research presented May 29 at a meeting of the American Society of Clinical Oncology revealed that current and former smokers who used Prempro for the treatment of menopausal symptoms and developed lung cancer were 60 percent more likely to die from the disease than women who weren't taking hormones. Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Couple Says Use Of Bayer's Oral Contraceptive Caused Gallbladder RemovalEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - A Louisiana couple alleges in a May 18 lawsuit filed in Pennsylvania federal court that the woman's use of oral contraceptive pills manufactured by Bayer Corp. caused her to sustain injuries that necessitated the removal of her gallbladder and that the company and its subsidiaries overstated the drugs' efficacy and failed to inform users about the correlation between the drugs' use and an increased risk of gallbladder injury (Adine Gauthreaux, et al. v. Bayer Corp., et al., No. 09-CV-2238-JP, E.D. Pa.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Ohio Couple Says Woman's Use of Yasmin Caused Severe Heart ArrhythmiasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TOLEDO, Ohio - A lawsuit filed in federal court June 9 by an Ohio couple claims that the woman's use of Yasmin caused her to suffer severe heart arrhythmias and that the manufacturers of the oral contraceptive are liable because they failed to adequately warn about the side effect and misrepresented the drug's safety and efficacy (Bridget Shafer, et al. v. Bayer Corp. et al., No. 09-cv-01315-JZ, N.D. Ohio). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

YAZ Makers Accused Of Failing To Warn About Risk Of Gallbladder InjuriesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CINCINNATI - An Ohio woman says in a May 29 lawsuit against the manufacturers of YAZ that her use of the oral contraceptive caused her to suffer injuries that required the removal of her gallbladder in June 2007 and that the company failed to adequately inform the public and the medical community that drospirenone, one of the drug's ingredients, is known to cause problems with the gallbladder (Heather Riley v. Bayer Corp., et al., No. 09 cv 387, S.D. Ohio). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

YAZ Caused Woman To Suffer Pulmonary Embolism, Couple SaysEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
TOLEDO, Ohio - The manufacturers of YAZ, an oral contraceptive containing drospirenone and ethinyl estradiol, are being sued in federal court by an Ohio couple who allege that the woman's use of the drug caused her to suffer a pulmonary embolism in 2007 and that the manufacturers of the drug are liable because they actively concealed and misrepresented the safety of the drug (Angela Beck, et al. v. Bayer Corp., et al., No. 09-cv-01207-JGC, N.D. Ohio). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - June 17, 2009 Category: Medical Law Source Type: info

Texas Appeals Court Reverses Preemption Ruling In Prempro CaseEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
HOUSTON - A state court judge's ruling that a woman's claims that Wyeth and Pfizer Inc. failed to adequately warn about the risk of breast cancer associated with the use of their hormone replacement therapies were preempted was reversed by an appellate court in Texas on April 14 based on the U.S. Supreme Court's ruling in Wyeth v. Levine (129 S. Ct. 1187; 173 L. Ed. 2d 51; 2009 U.S. LEXIS 1774), but the panel upheld the dismissal with prejudice of the plaintiff's design defect claims (Susan Brockert v. Wyeth, et al., No. 14-07-00445-CV, Texas App., 14th Dist.; 2009 Tex. App. LEXIS 2546; See February 2007, Page 6). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

3rd Circuit Vacates Colacicco, McNellis Rulings, Remands To Trial CourtsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - The Third Circuit U.S. Court of Appeals on April 28 reversed its drug preemption rulings in Joseph C. Colacicco, et al. v. Apotex Inc., et al. and Beth Ann McNellis, et al. v. Pfizer Inc. and remanded them to two U.S. district courts for further proceedings consistent with the U.S. Supreme Court's drug preemption ruling in Wyeth v. Diana Levine (No. 06-1249, U.S. Sup.; 2009 U.S. LEXIS 1774; See March 2009, Page 6) (Joseph C. Colacicco, et al. v. Apotex Inc., No. 06-3107, and Beth Ann McNellis, et al. v. Pfizer Inc., No. 06-5148, 3rd Cir.; See October 2006, Page 16). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Nexium/Prilosec Case Remanded In Wake Of Preemption RulingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - The Third Circuit U.S. Court of Appeals on May 5 remanded a Prilosec/Nexium consumer case after its preemption holding was reversed by the U.S. Supreme Court in Wyeth v. Diana Levine (No. 06-1249, U.S. Sup.; 2009 U.S. LEXIS 1774; See March 2009, Page 6) (Pennsylvania Employees Benefit Trust Fund, et al. v. Zeneca Inc., et al., No. 05-5340, 3rd Cir.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Ohio Couple's Request For Rehearing Of Prempro Appeal DeniedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA - An Ohio couple's request to have a Pennsylvania Superior Court panel rehear their arguments seeking reversal of a trial court judge's ruling that threw out a $3 million verdict awarded to them in their second trial against the manufacturer of Prempro was denied April 8 (Jennie Nelson, et al. v. Wyeth, No. 1520 EDA 2007, Pa. Super.; See February 2009, Page 5). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Prempro MDL Judge Denies Remand Pending Completion Of Generic DiscoveryEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - A plaintiff's request to remand her hormone replacement therapy injury case to the court that transferred it to the Prempro multidistrict litigation so it can proceed to trial was denied by the judge presiding over the proceedings on April 22 because the deadline for generic discovery is not scheduled until September 2009 and because remanding the case at this point would take the focus off of completing generic discovery (In re: Prempro Products Liability Litigation, MDL No. 1507, Case No. 03CV1507, Judy Wolf v. Wyeth, et al., No. 04CV19, E.D. Ark.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Judge Reinstates Couple's Premarin Lawsuit, Finds Dismissal Was In ErrorEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
EASTERN DUBUQUE, Iowa - A clerk of the court's dismissal of a couple's lawsuit against the manufacturer of Premarin was reversed April 14 by a federal judge who ruled that the plaintiffs did not need to file a statement as to why service of their complaint to the defendant was untimely because the clerk did not specifically tell them to do so (Patricia Keys, et al. v. Wyeth Inc., et al., No. C08-1023, N.D. Iowa; 2009 U.S. Dist. LEXIS 31819). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Pfizer's Acquisition Of Wyeth Will Have No Effect On Woman's ClaimsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
LITTLE ROCK, Ark. - The federal judge presiding over the Prempro multidistrict litigation on April 7 rejected a woman's request to reconsider an order dismissing her claims against Pfizer Inc. because it appeared that the plaintiff consented to dismissing her claims against the defendant and because Pfizer Inc.'s acquisition of Wyeth does not affect her claims against Pfizer (In re: Prempro Products Liability Litigation, MDL 1507, Case No. 03CV1507; Sharon Bland v. Wyeth, et al., No. 04CV1272, E.D. Ark.; 2009 U.S. Dist. LEXIS 29908). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Ortho Evra Maker Says Woman Was Not Using Product When She DiedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - The manufacturers of Ortho Evra say in an April 23 motion for summary judgment that a man's lawsuit should be dismissed because there is no evidence that his wife was using the birth control patch in the months before she suffered a fatal pulmonary embolism in 2004 and that the plaintiff should be sanctioned based on his conduct during discovery (In re: Ortho Evra Products Liability Litigation, MDL. 1742, Case No. 06-CV-40000, Stuart Weichsel v. Johnson & Johnson, et al., No. 07-40061, N.D. Ohio). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

New Jersey Judge Amends PFS To Disclose Other ActionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
NEW BRUNSWICK, N.J. - The New Jersey judge overseeing the state's Ortho Evra mass tort program on April 30 entered an order amending the Plaintiff's Fact Sheet (PFS) to include an area where plaintiffs should reveal if they have been involved in any other actions, settlements or tolling agreements with potentially liable parties (In re: Ortho Evra Birth Control Patch Litigation, Case No. 276, N.J. Super., Middlesex Co.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

NuvaRing MDL Plaintiffs Agree To Withdraw Class Claims From Master ComplaintEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. LOUIS - Plaintiffs in the NuvaRing multidistrict litigation said in an April 30 brief that they will not oppose the manufacturers' motion to strike class allegations from their master complaint but would not concede that "there is no situation which may develop in the MDL phase of this litigation that would justify the maintenance of a class action" and that they do not intend their decision not to oppose the motion to have any effect on future claims of a class action if made in an individual complaint (In re: NuvaRing Products Liability Litigation, MDL No. 1964, Case No. 08-md-1964, E.D. Mo.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - May 15, 2009 Category: Medical Law Source Type: info

Plaintiff's Affidavit Creates Genuine Issue Of Material Fact, Judge SaysEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - The federal judge presiding over the Ortho Evra products liability multidistrict litigation on March 27 denied a motion for summary judgment filed by the makers of the birth control patch after finding that a woman's affidavit in which she details her use of the patch and the symptoms that led to her hospitalization created genuine issues of material fact as to whether her injuries were caused by using the product (In re: Ortho Evra Products Liability Litigation, MDL No. 1742, Docket No. 06-40000; Kathleen Ann Nackley, et al. v. Johnson & Johnson, et al., No. 06-40046, N.D. Ohio; See March 2009, Page 12). ...
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - April 18, 2009 Category: Medical Law Source Type: info

Ortho Evra Makers Withdraw Preemption Motion In MDLEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CLEVELAND - The manufacturers of Ortho Evra on March 25 informed the judge presiding over the multidistrict litigation for cases involving injuries allegedly caused by the birth control patch that they are withdrawing their motion for summary judgment based on federal preemption but plan to refile the motion at a later date (In re: Ortho Evra Products Liability Litigation, MDL No. 1742, Case No. 06-cv-40000, N.D. Ohio; See April 2008, Page 10). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - April 18, 2009 Category: Medical Law Source Type: info

Nevada Judge Says Plaintiffs Can Consolidate Claims, Amend ComplaintEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
RENO, Nev. - A Nevada judge on March 26 granted two women's requests to consolidate their claims against the makers of Premarin, Prempro and Provera because the allegations involve similar legal and factual issues and allowed them to amend their complaint to include claims for innovator liability and deceptive trade practices after finding that adding the claims would not prejudice the defendants (Shelia Scott, et al. v. Wyeth, et al., No. CV04-1699, Nev. Dist., Washoe Co.). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - April 18, 2009 Category: Medical Law Source Type: info

HRT Makers Abandon Preemption Argument In Appealing Prempro VerdictEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ST. LOUIS - In reply briefs filed March 16, the makers of Premarin, Prempro and Provera abandoned their arguments seeking reversal of a $2.75 million verdict based in part on the preemption of a woman's claims that they failed to adequately warn about the risk of breast cancer due to the U.S. Supreme Court's ruling in Wyeth v. Levine (2009 U.S. LEXIS 1774 [U.S. Sup.]) and instead focused on whether specific and proximate causation evidence was properly admitted (Donna Scroggin v. Wyeth, et al., Nos. 08-2555, 08-2711, 08-2713, 8th Cir.; See March 2009, Page 4). Full story on lexis.com
Source: LexisNexis® Mealey's™ Hormone Replacement Therapy Legal News - April 18, 2009 Category: Medical Law Source Type: info

Pages: 1 2 3 4 5 6 7 8 9 10